75 results
8-K
EX-99.1
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
; whether the company can obtain and maintain third-party coverage and adequate reimbursement for PEMGARDA or any other product candidate; the company’s
8-K
EX-99.1
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
third-party coverage and adequate reimbursement for PEMGARDA or any other product candidate; the company’s ability to leverage its INVYMAB platform
8-K
EX-99.2
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
timely obtain and maintain third-party coverage and adequate reimbursement for PEMGARDA or any other product candidate; whether PEMGARDA or any other … main phases Product Securing Full Commercial Availability Reimbursement Implementation & Access Deploy national account managers Fully deploy
8-K
EX-99.1
m5gea4jf3dddypt
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
EX-99.1
83oyl6nwrsz3pp
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.3
sakx65y5wnq ih
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
h5ql8
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-99.1
6uimyrhj 3xmd
8 Jan 24
Other Events
7:12am
8-K
EX-99.1
pf8kaiw
3 Jan 24
Other Events
7:06am
8-K
EX-10.1
zgsxdwwpb5i0e
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
2lvd0er9u1utey
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am